T1324 Administrative Claims Data Analysis of Certolizumab Pegol in Crohn's Disease PTS Demonstrates Low Rates of Dose Escalation and High Compliance and Persistency
2019 ◽
Vol 123
(5)
◽
pp. S42-S43
2009 ◽
Vol 65
(10)
◽
pp. 2077-2087
◽
Keyword(s):